NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Nov 17, 2014
Insider Transaction Report
Form 4
GOLDBERG MICHAEL M
Director
Transactions
- Purchase
Common Stock
2014-11-13$1.06/sh+71,641$75,853→ 261,352 total - Purchase
Common Stock
2014-11-14$1.12/sh+28,359$31,890→ 289,711 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.0499 and $1.0727. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.09 and $1.13. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.